| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Quest Diagnostics and bioinformatics company Hc1 have announced the debut of Quest Lab Stewardship.
Secaucus-based Quest Diagnostics announced Tuesday that Manuel O. Méndez has been named senior vice president and chief commercial officer.[CR-LF][CR-LF]The provider of diagnostic information services said the appointment will be effective Oct. 7.[CR-LF][CR-LF]“Manuel is a seasoned and dynamic leader with more than 25 years of experience in diagnostics and life sciences,” Jim Davis, executive vice president, General Diagnostics, said. “His deep understanding of health systems and other customer segments will enable us to build on Quest’s strong Commercial foundation.”
Lab testing giant Quest Diagnostics has teamed up with healthcare data analysis company hc1 to try to prevent health systems from ordering too many or too few tests, the organizations announced Wednesday.[CR-LF]The Quest Lab Stewardship service aims to arm providers with the tools to order the right tests, retrieve results quickly, interpret them accurately and ensure reimbursement. The service integrates with the electronic medical record to guide doctors as they order test, creates a systemwide set of tests and analyzes utilization trends.
More people are high on the job, and it’s putting the public’s health and safety on the line.[CR-LF][CR-LF]One in three industries experienced double-digit percentage increases in the share of workers testing positive for a range of drugs between 2015 and 2018, according to a new analysis of more than 14 million urine drug tests results from Quest Diagnostics, a company that provides laboratory tests.
One third of U.S. industry sectors experienced year-over-year double-digit increases in workforce drug positivity between 2015 and 2018, according to a new analysis of industry-specific data by Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services. The findings will be presented at the Substance Abuse Program Administrators Association (SAPAA) conference in Philadelphia, PA on September 18, 2019.